D. Boral Capital Reaffirms “Buy” Rating for Nano-X Imaging (NASDAQ:NNOX)

Nano-X Imaging (NASDAQ:NNOX)‘s stock had its “buy” rating reaffirmed by research analysts at D. Boral Capital in a research note issued on Tuesday,Benzinga reports. They currently have a $8.00 target price on the stock. D. Boral Capital’s price objective points to a potential upside of 142.79% from the stock’s previous close.

A number of other analysts have also recently weighed in on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nano-X Imaging in a research note on Thursday. Alliance Global Partners upgraded shares of Nano-X Imaging to a “strong-buy” rating in a research note on Monday, August 11th. Two analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $8.50.

Nano-X Imaging Price Performance

Shares of NNOX traded up $0.47 during mid-day trading on Tuesday, reaching $3.30. 3,655,975 shares of the company’s stock were exchanged, compared to its average volume of 1,622,116. The stock has a market capitalization of $190.38 million, a PE ratio of -3.66 and a beta of 1.97. The business’s fifty day simple moving average is $3.77 and its 200-day simple moving average is $4.51. Nano-X Imaging has a 52-week low of $2.78 and a 52-week high of $11.00.

Institutional Trading of Nano-X Imaging

Institutional investors have recently modified their holdings of the business. PharVision Advisers LLC purchased a new position in Nano-X Imaging in the third quarter worth $56,000. Virtu Financial LLC grew its stake in shares of Nano-X Imaging by 253.8% during the 3rd quarter. Virtu Financial LLC now owns 57,366 shares of the company’s stock worth $212,000 after purchasing an additional 41,150 shares during the period. UBS Group AG increased its holdings in shares of Nano-X Imaging by 68.8% in the 3rd quarter. UBS Group AG now owns 1,086,645 shares of the company’s stock valued at $4,021,000 after purchasing an additional 442,899 shares in the last quarter. BNP Paribas Financial Markets lifted its stake in shares of Nano-X Imaging by 64.6% in the third quarter. BNP Paribas Financial Markets now owns 19,743 shares of the company’s stock valued at $73,000 after purchasing an additional 7,749 shares during the period. Finally, Russell Investments Group Ltd. lifted its stake in shares of Nano-X Imaging by 62.1% in the third quarter. Russell Investments Group Ltd. now owns 13,787 shares of the company’s stock valued at $51,000 after purchasing an additional 5,283 shares during the period. 21.49% of the stock is currently owned by hedge funds and other institutional investors.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.